161 related articles for article (PubMed ID: 14703016)
1. G protein mutations in pituitary tumors: a study on Turkish patients.
Kan B; Esapa C; Sipahi T; Nacar C; Ozer F; Sayhan NB; Kaynar MY; Sarioğlu AC; Harris PE
Pituitary; 2003 Sep; 6(2):75-80. PubMed ID: 14703016
[TBL] [Abstract][Full Text] [Related]
2. Impact of gsp oncogene on the expression of genes coding for Gsalpha, Pit-1, Gi2alpha, and somatostatin receptor 2 in human somatotroph adenomas: involvement in octreotide sensitivity.
Barlier A; Pellegrini-Bouiller I; Gunz G; Zamora AJ; Jaquet P; Enjalbert A
J Clin Endocrinol Metab; 1999 Aug; 84(8):2759-65. PubMed ID: 10443675
[TBL] [Abstract][Full Text] [Related]
3. G protein abnormalities in pituitary adenomas.
Spada A; Lania A; Ballarè E
Mol Cell Endocrinol; 1998 Jul; 142(1-2):1-14. PubMed ID: 9783897
[TBL] [Abstract][Full Text] [Related]
4. Gs alpha and Gi2 alpha mutations in clinically non-functioning pituitary tumours.
Williamson EA; Daniels M; Foster S; Kelly WF; Kendall-Taylor P; Harris PE
Clin Endocrinol (Oxf); 1994 Dec; 41(6):815-20. PubMed ID: 7889619
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Gs alpha mutations in Korean patients with pituitary adenomas.
Kim HJ; Kim MS; Park YJ; Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Jung HW; Han DH; Lee HS; Chi JG
J Endocrinol; 2001 Feb; 168(2):221-6. PubMed ID: 11182759
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of protein kinase A catalytic subunit in thyroid adenomas and pituitary tumours.
Esapa CT; Harris PE
Eur J Endocrinol; 1999 Oct; 141(4):409-12. PubMed ID: 10526256
[TBL] [Abstract][Full Text] [Related]
7. Gip-2 codon 179 oncogene mutations: absent in adrenal cortical tumors.
Demeure MJ; Doffek KM; Komorowski RA; Gorski J
World J Surg; 1996 Sep; 20(7):928-31; discussion 931-2. PubMed ID: 8678943
[TBL] [Abstract][Full Text] [Related]
8. G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas.
Williamson EA; Ince PG; Harrison D; Kendall-Taylor P; Harris PE
Eur J Clin Invest; 1995 Feb; 25(2):128-31. PubMed ID: 7737262
[TBL] [Abstract][Full Text] [Related]
9. Clonal composition of human adamantinomatous craniopharyngiomas and somatic mutation analyses of the patched (PTCH), Gsalpha and Gi2alpha genes.
Sarubi JC; Bei H; Adams EF; Boson WL; Friedman E; Brandão K; Kalapothakis E; Miranda D; Valle FL; Sarquis MS; De Marco L
Neurosci Lett; 2001 Sep; 310(1):5-8. PubMed ID: 11524144
[TBL] [Abstract][Full Text] [Related]
10. Activating mutations of the Gs alpha-gene in nonfunctioning pituitary tumors.
Tordjman K; Stern N; Ouaknine G; Yossiphov Y; Razon N; Nordenskjöld M; Friedman E
J Clin Endocrinol Metab; 1993 Sep; 77(3):765-9. PubMed ID: 8396579
[TBL] [Abstract][Full Text] [Related]
11. Molecular screening for somatic mutations in corticotropic adenomas of dogs with pituitary-dependent hyperadrenocorticism.
van Wijk PA; Rijnberk A; Croughs RJ; Meij BP; van Leeuwen IS; Sprang EP; Mol JA
J Endocrinol Invest; 1997 Jan; 20(1):1-7. PubMed ID: 9075064
[TBL] [Abstract][Full Text] [Related]
12. Absence of somatostatin receptor type 2 A mutations and gip oncogene in pituitary somatotroph adenomas.
Petersenn S; Heyens M; Lüdecke DK; Beil FU; Schulte HM
Clin Endocrinol (Oxf); 2000 Jan; 52(1):35-42. PubMed ID: 10651751
[TBL] [Abstract][Full Text] [Related]
13. [Endocrine tumors associated to protein Gsalpha/Gi2alpha mutations].
Bezerra MG; Latronico AC; Fragoso MC
Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):784-90. PubMed ID: 16444361
[TBL] [Abstract][Full Text] [Related]
14. Gs protein mutations and the pathogenesis and function of pituitary tumors.
Harris PE
Metabolism; 1996 Aug; 45(8 Suppl 1):120-2. PubMed ID: 8769404
[TBL] [Abstract][Full Text] [Related]
15. Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors.
Fragoso MC; Latronico AC; Carvalho FM; Zerbini MC; Marcondes JA; Araujo LM; Lando VS; Frazzatto ET; Mendonca BB; Villares SM
J Clin Endocrinol Metab; 1998 Jun; 83(6):2074-8. PubMed ID: 9626141
[TBL] [Abstract][Full Text] [Related]
16. G protein and thyrotropin receptor mutations in thyroid neoplasia.
Esapa C; Foster S; Johnson S; Jameson JL; Kendall-Taylor P; Harris PE
J Clin Endocrinol Metab; 1997 Feb; 82(2):493-6. PubMed ID: 9024242
[TBL] [Abstract][Full Text] [Related]
17. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclic adenosine 3',5'-monophosphate (cAMP)-responsive element binding protein and inducible-cAMP early repressor genes in growth hormone-secreting pituitary adenomas with or without mutations of the Gsalpha gene.
Peri A; Conforti B; Baglioni-Peri S; Luciani P; Cioppi F; Buci L; Corbetta S; Ballaré E; Serio M; Spada A
J Clin Endocrinol Metab; 2001 May; 86(5):2111-7. PubMed ID: 11344215
[TBL] [Abstract][Full Text] [Related]
19. Glycoprotein hormone alpha-subunit production in somatotroph adenomas with and without Gs alpha mutations.
Harris PE; Alexander JM; Bikkal HA; Hsu DW; Hedley-Whyte ET; Klibanski A; Jameson JL
J Clin Endocrinol Metab; 1992 Sep; 75(3):918-23. PubMed ID: 1517386
[TBL] [Abstract][Full Text] [Related]
20. Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly.
Hayward BE; Barlier A; Korbonits M; Grossman AB; Jacquet P; Enjalbert A; Bonthron DT
J Clin Invest; 2001 Mar; 107(6):R31-6. PubMed ID: 11254676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
